TY - JOUR
T1 - Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)
AU - Wen, PY
AU - Cloughesy, TF
AU - Ellingson, BM
AU - Reardon, DA
AU - Fine, HA
AU - Abrey, L
AU - Ballman, K
AU - Bendszuz, M
AU - Buckner, J
AU - Chang, SM
AU - Prados, MD
AU - Pope, WB
AU - Sorensen, AG
AU - van den Bent, Martin
AU - Yung, WKA
PY - 2014
Y1 - 2014
N2 - On January 30, 2014, a workshop was held on neuroimaging endpoints in high-grade glioma. This workshop was sponsored by the Jumpstarting Brain Tumor Drug Development Coalition, consisting of the National Brain Tumor Society, the Society for Neuro-Oncology, Accelerate Brain Cancer Cure, and the Musella Foundation for Research and Information, and conducted in collaboration with the Food and Drug Administration. The workshop included neuro-oncologists, neuroradiologists, radiation oncologists, neurosurgeons, biostatisticians, patient advocates, and representatives from industry, clinical research organizations, and the National Cancer Institute. This report summarizes the presentations and discussions of that workshop and the proposals that emerged to improve the Response Assessment in Neuro-Oncology (RANO) criteria and standardize neuroimaging parameters.
AB - On January 30, 2014, a workshop was held on neuroimaging endpoints in high-grade glioma. This workshop was sponsored by the Jumpstarting Brain Tumor Drug Development Coalition, consisting of the National Brain Tumor Society, the Society for Neuro-Oncology, Accelerate Brain Cancer Cure, and the Musella Foundation for Research and Information, and conducted in collaboration with the Food and Drug Administration. The workshop included neuro-oncologists, neuroradiologists, radiation oncologists, neurosurgeons, biostatisticians, patient advocates, and representatives from industry, clinical research organizations, and the National Cancer Institute. This report summarizes the presentations and discussions of that workshop and the proposals that emerged to improve the Response Assessment in Neuro-Oncology (RANO) criteria and standardize neuroimaging parameters.
U2 - 10.1093/neuonc/nou226
DO - 10.1093/neuonc/nou226
M3 - Article
C2 - 25313237
SN - 1522-8517
VL - 16
SP - 36
EP - 47
JO - Neuro-Oncology
JF - Neuro-Oncology
ER -